Aspects related to biofilm production and antifungal susceptibility of clinically relevant yeasts of the genus Trichosporon.


Journal

Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835

Informations de publication

Date de publication:
02 Mar 2023
Historique:
received: 05 12 2022
revised: 09 02 2023
accepted: 15 02 2023
pubmed: 23 2 2023
medline: 24 3 2023
entrez: 22 2 2023
Statut: ppublish

Résumé

Trichosporonosis corresponds to a systemic fungal disease that leads to high mortality rates and is frequently associated with medical devices. It affects immunosuppressed patients in particular and is strongly linked to acquired human immunodeficiency, organ and tissue transplants, and malignant hematologic diseases such as leukemia and lymphomas. Trichosporon infections have been increasingly reported worldwide; however, little information is available either about their characteristics or the causative microorganism. Thus, the aims of the present study were: to investigate 59 yeasts of the genus Trichosporon by verifying the biofilm formation capacity of isolates; to analyze the susceptibility patterns of planktonic cells against the antifungals fluconazole, itraconazole, amphotericin-B, voriconazole, and caspofungin by comparing European Committee for Antimicrobial Susceptibility Testing (EUCAST) broth microdilution technique with the commercial method Etest; and to assess the susceptibility patterns of biofilm cells (sessile) against the same antifungals through broth microdilution. The ability to form biofilm on the surface of polystyrene plates was noted for all isolates, and 54.3% of samples were considered strong producers. Comparison between the antifungal susceptibility techniques evidenced that Etest showed higher and discordant minimum inhibitory concentrations (MICs) from those obtained by the microdilution method, especially for fluconazole, itraconazole, and caspofungin. Considering the susceptibility of biofilms, most species had high MIC50 and MIC90 against the tested antifungals, showing 4-to-66-fold higher concentrations for amphotericin B and 2-to-33-fold greater concentrations for caspofungin. These results highlight the importance of further studies with Trichosporon spp. for comparison between laboratory findings and in vivo response, considering both the susceptibility tests and the behavior of biofilm cells against drugs. This study investigated 59 isolates of the medically important yeast Trichosporon in relation to their ability to form biofilms and the susceptibility of biofilms to antifungal agents. All isolates were able to produce biofilms and biofilms showed lower antifungal susceptibility.

Autres résumés

Type: plain-language-summary (eng)
This study investigated 59 isolates of the medically important yeast Trichosporon in relation to their ability to form biofilms and the susceptibility of biofilms to antifungal agents. All isolates were able to produce biofilms and biofilms showed lower antifungal susceptibility.

Identifiants

pubmed: 36807459
pii: 7044775
doi: 10.1093/mmy/myad022
pii:
doi:

Substances chimiques

Antifungal Agents 0
Fluconazole 8VZV102JFY
Caspofungin F0XDI6ZL63
Itraconazole 304NUG5GF4
Amphotericin B 7XU7A7DROE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Foundation for Research Support of the State of São Paulo
ID : 2019/08419-7

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Auteurs

Bruna Rossini Lara (BR)

Instituto de Biociências, Universidade Estadual Paulista (UNESP) , Botucatu, São Paulo, Brazil.
Instituto Adolfo Lutz (IAL)-CLR II, Núcleo de Ciências Biomédicas, Bauru, São Paulo, Brazil.

Bruno Braidotti de Camargo (BB)

Instituto Adolfo Lutz (IAL)-CLR II, Núcleo de Ciências Biomédicas, Bauru, São Paulo, Brazil.

Claudete Rodrigues Paula (CR)

Faculdade de Odontologia, Universidade de São Paulo (USP), São Paulo, SP, Brazil.

Gabrielle Pires de Morais Monari (GPM)

Instituto Adolfo Lutz (IAL)-CLR II, Núcleo de Ciências Biomédicas, Bauru, São Paulo, Brazil.

Hans Garcia Garces (HG)

Instituto de Biociências, Universidade Estadual Paulista (UNESP) , Botucatu, São Paulo, Brazil.

Mariana Volpe Arnoni (MV)

Irmandade da Santa Casa de Misericórdia de São Paulo, Serviço de Controle de Infecção Hospitalar, São Paulo, SP, Brazil.
Hospital Infantil Darcy Vargas, São Paulo, SP, Brazil.

Mônica Silveira (M)

Hospital Estadual Bauru (HEB), Bauru, SP, Brazil.

Viviane Mazo Fávero Gimenes (VMF)

Instituto de Medicina Tropical, Universidade de São Paulo (USP), São Paulo, SP, Brazil.

Diniz Pereira Leite Junior (DP)

Instituto Adolfo Lutz (IAL) Central, Centro de Parasitologia e Micologia, São Paulo, SP, Brazil.

Lucas Xavier Bonfietti (LX)

Instituto Adolfo Lutz (IAL) Central, Centro de Parasitologia e Micologia, São Paulo, SP, Brazil.

Lidiane Oliveira (L)

Instituto Adolfo Lutz (IAL) Central, Centro de Parasitologia e Micologia, São Paulo, SP, Brazil.

Márcia de Souza Carvalho Melhem (MSC)

Instituto Adolfo Lutz (IAL) Central, Centro de Parasitologia e Micologia, São Paulo, SP, Brazil.
Programa de Pós-Graduação em Doenças Infecciosas, Universidade Federal do Mato Grosso do Sul, MS, Brazil.

Marcos Auler (M)

Faculdade de Farmácia, Universidade Estadual do Centro Oeste (UNICENTRO), Guarapuava, PR, Brazil.

Regina Teixeira Barbieri Ramos (RTB)

Faculdade de Odontologia, Universidade de São Paulo (USP), São Paulo, SP, Brazil.

Amanda Latercia Tranches Dias (ALT)

Instituto de Ciências Biomédicas, Universidade Federal de Alfenas (UNIFAL), Alfenas, MG, Brazil.

Naiara Chaves Silva (NC)

Instituto de Ciências Biomédicas, Universidade Federal de Alfenas (UNIFAL), Alfenas, MG, Brazil.

Débora Moreira (D)

Faculdade de Odontologia, Universidade de São Paulo (USP), São Paulo, SP, Brazil.

Virgínia Bodelão Richini-Pereira (VB)

Instituto Adolfo Lutz (IAL)-CLR II, Núcleo de Ciências Biomédicas, Bauru, São Paulo, Brazil.

Laís Anversa (L)

Instituto Adolfo Lutz (IAL)-CLR II, Núcleo de Ciências Biomédicas, Bauru, São Paulo, Brazil.

Luciana da Silva Ruiz (LDS)

Instituto de Biociências, Universidade Estadual Paulista (UNESP) , Botucatu, São Paulo, Brazil.
Instituto Adolfo Lutz (IAL)-CLR II, Núcleo de Ciências Biomédicas, Bauru, São Paulo, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH